tradingkey.logo

Proqr Announces Encouraging Ax-0810 Phase 1

ReutersJan 8, 2026 1:39 PM

- ProQR Therapeutics NV PRQR.O:

  • PROQR ANNOUNCES ENCOURAGING AX-0810 PHASE 1 SAFETY AND PK DATA, DEVELOPMENT CANDIDATE SELECTIONS, AND 2026 OUTLOOK

  • PROQR THERAPEUTICS NV: INITIAL AX-0810 DATA SHOW NO SAFETY SIGNALS AFTER 4 WEEKS OF DOSING AND PHARMACOKINETICS CONSISTENT WITH NON-CLINICAL DATA

  • PROQR THERAPEUTICS NV: PHASE 1 AX-0810 DATA EXPECTED IN H1 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI